Protagonist Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.

CEO

Dinesh V. Patel

CEODinesh V. Patel

Employees

126

Employees126

Headquarters

Newark, California

HeadquartersNewark, California

Founded

2006

Founded2006

Employees

126

Employees126

PTGX Key Statistics

Market cap

3.45B

Market cap3.45B

Price-Earnings ratio

73.21

Price-Earnings ratio73.21

Dividend yield

—

Dividend yield—

Average volume

1.08M

Average volume1.08M

High today

$55.90

High today$55.90

Low today

$54.71

Low today$54.71

Open price

$55.34

Open price$55.34

Volume

1.26M

Volume1.26M

52 Week high

$60.60

52 Week high$60.60

52 Week low

$32.50

52 Week low$32.50

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell

People also own

Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.